What's next for the stock? We take a look at earnings estimates for some clues. The mean of analysts' price targets for Exact Sciences (EXAS) points to a 34.3% upside in the stock. While this ...

Exact Sciences stock tumbled early Thursday in a move analysts called "overdone" and "overblown" as fears of a sales slowdown ...

Exact Sciences stock bounded higher Thursday after beating second-quarter expectations, signaling a return to growth for its ...

Here's is How to Trade Exact Sciences (NASDAQ: EXAS) closed the last trading session at $59.11, gaining 3.7% over the past four weeks, but there could be plenty of upside left in the stock if ...

Exact Sciences (EXAS) stock rises as company announces release of data for blood-based cancer test on August 16. Read more ...

In terms of liquidity and interest, the mean open interest for Exact Sciences options trades today is 1016.57 with a total ...

Exact Sciences Corp (EXAS) stock saw a modest uptick, ending the day at $69.21 which represents a slight increase of $1.22 or 1.79% from the prior close of $67.99. The stock opened at $68.14 and ...

Columbia Acorn Fund, distributed by Columbia Management Investment Distributors, released its second quarter 2024 investor ...

The initial results suggest that Exact’s test could be an alternative to others on the market, but the findings come from a ...

Exact Sciences (EXAS – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Mark ...

Analyst Brandon Couillard of Wells Fargo maintained a Buy rating on Exact Sciences (EXAS – Research Report), retaining the price target ...

Exact Sciences Corp (EXAS) stock saw a modest uptick, ending the day at $64.12 which represents a slight increase of $5.74 or 9.83% from the prior close of $58.38. The stock opened at $58.46 and ...